Background The clinical benefit of LDL cholesterol lowering treatment in older patients
remains debated. We aimed to summarise the evidence of LDL cholesterol lowering …

Background Current evidence from randomized controlled trials on statins for primary
prevention of cardiovascular disease (CVD) in older people, especially those aged> 75 …

Importance Statin use is common in older persons. Given uncertainties in ongoing benefit,
changes in health status, and shifting goals of care and preferences, statin discontinuation …

Introduction Migraine, a prevalent headache disorder with unclear mechanisms and limited
treatments, may be influenced by dyslipidemia and genetic factors. Statins and emerging …

Background Dyslipidaemia plays an important role in coronary atherosclerotic disease
(CAD). The relationship between the atherogenic index of plasma (AIP) and CAD in elderly …

Introduction Research is ongoing to increase our understanding of how much a previous
diagnosis of type 2 diabetes mellitus (T2DM) affects someone's risk of becoming seriously …

Aims The importance of standard modifiable cardiovascular risk factors (SMuRFs) in
preventing non-ST-segment elevation myocardial infarction (NSTEMI) is established …

Importance There are limited data for the utility of statins for primary prevention of
atherosclerotic cardiovascular disease (ASCVD) and death in adults with chronic kidney …

Background Reducing low-density lipoprotein (LDL) cholesterol with lipid-lowering therapy
has consistently been shown to lower the risk of cardiovascular disease in primary …

Lipid-lowering drugs (LLDs) have protective effects against coronary artery disease (CAD)
and cerebrovascular disease (CVD); however, a paradoxical association with cholesterol …